Curia Makes Significant Strides In Net Zero Pledges

KUALA LUMPUR, Oct 9 (Bernama) -- Curia announced its commitment to set near- and long-term company-wide greenhouse gas (GHG) emission reductions in line with science-based net zero with the Science Based Targets initiative (SBTi).

According to Curia in a statement, to achieve this goal, the company will be investing resources over the next two years to evaluate and develop GHG emission reduction targets for submission to and approval by the SBTi.

“Our targets are ambitious, but we recognise the urgency and importance of cutting emissions in the near-term. With facilities in the United States, Europe and Asia, our actions can have a significant effect on communities on a global scale.

“Environmental stewardship has long been a priority for Curia, and this pledge underscores our commitment to continuous improvement in reducing our environmental impact and bringing us closer to a more sustainable future,” said its chief executive officer, Philip Macnabb.

The net-zero commitment is another step forward for Curia’s Environmental, Social and Governance (ESG) programme, a cross-functional team that advances the company’s environmental and social stewardship with sound corporate governance.

Its ESG programme links with the Environmental, Health and Safety (EHS) management system, modelled after ISO 14001 and 45001, the global standards for environmental management systems and occupational health and safety management systems.

Curia’s EHS management system is grounded on eight key pillars that serve as the framework to deliver measurable improvements year-over-year, and sustainability is one key pillar within that framework that underlies the net-zero commitment.

With this commitment, Curia also joins the United Nations’ Race to Zero campaign, a global coalition of non-state actors working toward halving global emissions by 2030.

Curia is a contract research, development and manufacturing organisation, with over 30 years of experience, an integrated network of over 20 global sites and 3,500 employees partnering with biopharmaceutical customers to bring life-changing therapies to market.

-- BERNAMA